Zeria Pharmaceutical Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Japan.
P/E ratio
10.6Investors pay 10.6 for every 1 of Zeria Pharmaceutical Co., Ltd.'s yearly profit, lower than 87% of Healthcare companies in Japan.
P/B ratio
0.81The share price is 0.81 times Zeria Pharmaceutical Co., Ltd.'s book value per share, lower than 86% of Healthcare companies in Japan.
Market cap
¥87.3 BThe total market value of all of Zeria Pharmaceutical Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 60% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Return on equity (ROE)
8.4%Zeria Pharmaceutical Co., Ltd. earned 8.4% on its shareholders' money over the last year, lower than 59% of Healthcare companies in Japan.
Dividend yield
2.46%Zeria Pharmaceutical Co., Ltd. pays 2.46% of its share price as dividends a year, lower than 58% of dividend-paying Healthcare companies in Japan.
Questions
What is Zeria Pharmaceutical Co., Ltd.'s P/E ratio?
Investors pay 10.6 for every 1 of Zeria Pharmaceutical Co., Ltd.'s yearly profit, lower than 87% of Healthcare companies in Japan.
What is Zeria Pharmaceutical Co., Ltd.'s return on equity?
Zeria Pharmaceutical Co., Ltd. earned 8.4% on its shareholders' money over the last year, lower than 59% of Healthcare companies in Japan.
Does Zeria Pharmaceutical Co., Ltd. pay a dividend?
Yes. Zeria Pharmaceutical Co., Ltd. pays 2.46% of its share price as dividends a year, lower than 58% of dividend-paying Healthcare companies in Japan.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.